Genfit SA (GNFT):企業の財務・戦略的SWOT分析

◆英語タイトル:Genfit SA (GNFT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH58846FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, NASH, TGFTX1 and Nitazoxanide (NTZ). Its TGFTX1 is a research program for neutrophilic asthma, chronic obstructive pulmonary disease and the asthma-COPD overlap syndrome (ACOS); NASH for treatment of liver diseases and NTZ for fibrotic diseases. Genfit develops diagnostic solutions in various therapeutic areas such as metabolic diseases, cholestatic liver diseases, inflammation and autoimmune diseases, and fibrotic diseases. The company’s research and development activities include multiple drug candidate research programs targeting novel mechanisms of action such as the inhibition of nuclear receptors ROR (a, ß, ?). It has presence in France and the US. Genfit is headquartered in Loos, France.

Genfit SA Key Recent Developments

Apr 01,2021: GENFIT Reports Full-Year 2020 Financial Results and Provides Corporate Update
Mar 04,2021: GENFIT appoints Jean-François Tiné to the Board of Directors
Jan 28,2021: GENFIT announces two key appointments to the Executive Committee
Jan 11,2021: GENFIT: Half-year report of liquidity contract with credit Industriel et Commercial
Nov 16,2020: Genfit: Third quarter 2020 financial information and launch of renegotiation of convertible bond

This comprehensive SWOT profile of Genfit SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Genfit SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Genfit SA – Key Information
Genfit SA – Overview
Genfit SA – Key Employees
Genfit SA – Key Employee Biographies
Genfit SA – Key Operational Heads
Genfit SA – Major Products and Services
Genfit SA – History
Genfit SA – Company Statement
Genfit SA – Locations And Subsidiaries
Genfit SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Genfit SA – Business Description
Genfit SA – Corporate Strategy
Genfit SA – SWOT Analysis
SWOT Analysis – Overview
Genfit SA – Strengths
Genfit SA – Weaknesses
Genfit SA – Opportunities
Genfit SA – Threats
Genfit SA – Key Competitors

Section 3 – Company Financial Performance Charts

Genfit SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Genfit SA, Key Information
Genfit SA, Key Ratios
Genfit SA, Share Data
Genfit SA, Major Products and Services
Genfit SA, History
Genfit SA, Key Employees
Genfit SA, Key Employee Biographies
Genfit SA, Key Operational Heads
Genfit SA, Other Locations
Genfit SA, Subsidiaries
Genfit SA, Key Competitors
Genfit SA, SWOT Analysis
Genfit SA, Ratios based on current share price
Genfit SA, Annual Ratios
Genfit SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Genfit SA (GNFT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Selecta Biosciences Inc (SELB)-製薬・医療分野:企業M&A・提携分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a clinical-stage biopharmaceutical company which develops immunotherapies and vaccines to prevent and treat disease. The company’s pipeline products include SEL-212, SELA-070, SEL-701, LMB-100 and others. Its synthetic vaccine particle (SVP) t …
  • Oasis Petroleum Inc (OAS):企業の財務・戦略的SWOT分析
    Oasis Petroleum Inc (OAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dave & Buster’s Entertainment, Inc.:企業の戦略・SWOT・財務情報
    Dave & Buster's Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dave & Buster's Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Esperite NV (ESP):企業の財務・戦略的SWOT分析
    Esperite NV (ESP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ecopetrol SA (ECOPETROL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ecopetrol SA (Ecopetrol) is a vertically integrated oil and gas company that carries out exploration, development and production of oil and gas. It is also involved in refining of crude oil to produce petroleum products, besides transportation services. Ecopetrol owns and operates refineries …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Coca-Cola Consolidated Inc (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Consolidated Inc (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bashas’ Inc.:企業の戦略・SWOT・財務情報
    Bashas' Inc. - Strategy, SWOT and Corporate Finance Report Summary Bashas' Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Petrobras Argentina SA:企業の戦略的SWOT分析
    Petrobras Argentina SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Synairgen Plc (SNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its pipeline portfolio includes inhaled interferon beta (IFN-ß/SNG …
  • Thai Union Frozen Products Public Company Limited:企業の戦略・SWOT・財務情報
    Thai Union Frozen Products Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Union Frozen Products Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • NICO Life Insurance Co Ltd:企業の戦略的SWOT分析
    NICO Life Insurance Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Healthscope Ltd (HSO):企業の財務・戦略的SWOT分析
    Healthscope Ltd (HSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TSO3 Inc (TOS):医療機器:M&Aディール及び事業提携情報
    Summary TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The co …
  • CytoSorbents Corp (CTSO):企業の財務・戦略的SWOT分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriou …
  • Crispin Speers & Partners Limited:企業の戦略・SWOT・財務情報
    Crispin Speers & Partners Limited - Strategy, SWOT and Corporate Finance Report Summary Crispin Speers & Partners Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Adaptimmune Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Adaptimmune Ltd (Adaptimmune) a subsidiary of Adaptimmune Therapeutics plc operates as a clinical trials and pipeline company. The company engaged in developing T-cell receptors for T-cell therapy and SPEAR TCR therapies. Its clinical trials include synovial sarcoma trial, multiple myeloma t …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆